Kura Oncology to Participate in Three Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that management is scheduled to participate in three investor conferences in September.
Read more at globenewswire.com
